A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab
Titel:
A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab
Auteur:
Mathieu, Chantal Wiedeman, Alice Cerosaletti, Karen Long, S. Alice Serti, Elisavet Cooney, Laura Vermeiren, Joan Caluwaerts, Silvia Van Huynegem, Karolien Steidler, Lothar Blomme, Sven Rottiers, Pieter Nepom, Gerald T. Herold, Kevan C. ,